These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 22421275)
1. Tuberculosis: the drug development pipeline at a glance. Villemagne B; Crauste C; Flipo M; Baulard AR; Déprez B; Willand N Eur J Med Chem; 2012 May; 51():1-16. PubMed ID: 22421275 [TBL] [Abstract][Full Text] [Related]
2. The anti-tuberculosis agents under development and the challenges ahead. Kumar D; Negi B; Rawat DS Future Med Chem; 2015; 7(15):1981-2003. PubMed ID: 26505682 [TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
4. Antimycobacterial drugs currently in Phase II clinical trials and preclinical phase for tuberculosis treatment. Engohang-Ndong J Expert Opin Investig Drugs; 2012 Dec; 21(12):1789-800. PubMed ID: 22991970 [TBL] [Abstract][Full Text] [Related]
5. New anti-tuberculosis drugs in clinical trials with novel mechanisms of action. Rivers EC; Mancera RL Drug Discov Today; 2008 Dec; 13(23-24):1090-8. PubMed ID: 18840542 [TBL] [Abstract][Full Text] [Related]
7. New drugs for the treatment of tuberculosis: hope and reality. Grosset JH; Singer TG; Bishai WR Int J Tuberc Lung Dis; 2012 Aug; 16(8):1005-14. PubMed ID: 22762423 [TBL] [Abstract][Full Text] [Related]
8. Rip Van Winkle wakes up: development of tuberculosis treatment in the 21st century. Burman WJ Clin Infect Dis; 2010 May; 50 Suppl 3():S165-72. PubMed ID: 20397944 [TBL] [Abstract][Full Text] [Related]
9. Tackling Drug-Resistant Tuberculosis: Current Trends and Approaches. Tandon R; Nath M Mini Rev Med Chem; 2017; 17(6):549-570. PubMed ID: 27280980 [TBL] [Abstract][Full Text] [Related]
10. OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice. Matsumoto M; Hashizume H; Tomishige T; Kawasaki M; Tsubouchi H; Sasaki H; Shimokawa Y; Komatsu M PLoS Med; 2006 Nov; 3(11):e466. PubMed ID: 17132069 [TBL] [Abstract][Full Text] [Related]
11. New tuberculosis drugs on the horizon. Cole ST; Riccardi G Curr Opin Microbiol; 2011 Oct; 14(5):570-6. PubMed ID: 21821466 [TBL] [Abstract][Full Text] [Related]
12. Challenges and opportunities in developing novel drugs for TB. Kaneko T; Cooper C; Mdluli K Future Med Chem; 2011 Sep; 3(11):1373-400. PubMed ID: 21879843 [TBL] [Abstract][Full Text] [Related]
13. Managing TB in the 21st century: existing and novel drug therapies. Guy ES; Mallampalli A Ther Adv Respir Dis; 2008 Dec; 2(6):401-8. PubMed ID: 19124385 [TBL] [Abstract][Full Text] [Related]
14. Toward an optimized therapy for tuberculosis? Drugs in clinical trials and in preclinical development. Ma Z; Lienhardt C Clin Chest Med; 2009 Dec; 30(4):755-68, ix. PubMed ID: 19925965 [TBL] [Abstract][Full Text] [Related]
15. Novel compounds and drugs and recent patents in treating multidrug-resistant and extensively drug-resistant tuberculosis. Cheepsattayakorn A; Cheepsattayakorn R Recent Pat Antiinfect Drug Discov; 2012 Aug; 7(2):141-56. PubMed ID: 22670838 [TBL] [Abstract][Full Text] [Related]
16. New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmes. Lienhardt C; Vernon A; Raviglione MC Curr Opin Pulm Med; 2010 May; 16(3):186-93. PubMed ID: 20216421 [TBL] [Abstract][Full Text] [Related]
17. Drugs in development for tuberculosis. Ginsberg AM Drugs; 2010 Dec; 70(17):2201-14. PubMed ID: 21080738 [TBL] [Abstract][Full Text] [Related]
18. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
19. Improving the tuberculosis drug development pipeline. Evangelopoulos D; McHugh TD Chem Biol Drug Des; 2015 Nov; 86(5):951-60. PubMed ID: 25772393 [TBL] [Abstract][Full Text] [Related]